These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 30018981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression profile of IGF system during lung injury and recovery in rats exposed to hyperoxia: a possible role of IGF-1 in alveolar epithelial cell proliferation and differentiation.
    Narasaraju TA, Chen H, Weng T, Bhaskaran M, Jin N, Chen J, Chen Z, Chinoy MR, Liu L.
    J Cell Biochem; 2006 Apr 01; 97(5):984-98. PubMed ID: 16288470
    [Abstract] [Full Text] [Related]

  • 3. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul 01; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 4. The insulin-like growth factor pathway in lung cancer.
    Dziadziuszko R, Camidge DR, Hirsch FR.
    J Thorac Oncol; 2008 Aug 01; 3(8):815-8. PubMed ID: 18670298
    [Abstract] [Full Text] [Related]

  • 5. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan.
    Carter CS, Ramsey MM, Sonntag WE.
    Trends Genet; 2002 Jun 01; 18(6):295-301. PubMed ID: 12044358
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor (IGF) axis in cancerogenesis.
    Kasprzak A, Kwasniewski W, Adamek A, Gozdzicka-Jozefiak A.
    Mutat Res Rev Mutat Res; 2017 Jun 01; 772():78-104. PubMed ID: 28528692
    [Abstract] [Full Text] [Related]

  • 7. Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury.
    Veness-Meehan KA, Moats-Staats BM, Price WA, Stiles AD.
    Am J Respir Cell Mol Biol; 1997 May 01; 16(5):538-48. PubMed ID: 9160836
    [Abstract] [Full Text] [Related]

  • 8. The insulin-like growth factors and the lung.
    Stiles AD, D'Ercole AJ.
    Am J Respir Cell Mol Biol; 1990 Aug 01; 3(2):93-100. PubMed ID: 2165791
    [Abstract] [Full Text] [Related]

  • 9. Insulin and insulin-like growth factor-1 modulate the lipolytic action of growth hormone by altering signal pathway linkages.
    Bergan-Roller HE, Ickstadt AT, Kittilson JD, Sheridan MA.
    Gen Comp Endocrinol; 2017 Jul 01; 248():40-48. PubMed ID: 28410970
    [Abstract] [Full Text] [Related]

  • 10. Biological & physiological aspects of action of insulin-like growth factor peptide family.
    Pavelić J, Matijević T, Knezević J.
    Indian J Med Res; 2007 Apr 01; 125(4):511-22. PubMed ID: 17598937
    [Abstract] [Full Text] [Related]

  • 11. Role of insulin-like growth factor I signaling in neurodegenerative diseases.
    Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I.
    J Mol Med (Berl); 2004 Mar 01; 82(3):156-62. PubMed ID: 14647921
    [Abstract] [Full Text] [Related]

  • 12. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung.
    Homma S, Nagaoka I, Abe H, Takahashi K, Seyama K, Nukiwa T, Kira S.
    Am J Respir Crit Care Med; 1995 Dec 01; 152(6 Pt 1):2084-9. PubMed ID: 8520779
    [Abstract] [Full Text] [Related]

  • 13. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis.
    Uh ST, Inoue Y, King TE, Chan ED, Newman LS, Riches DW.
    Am J Respir Crit Care Med; 1998 Nov 01; 158(5 Pt 1):1626-35. PubMed ID: 9817718
    [Abstract] [Full Text] [Related]

  • 14. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
    Yakar S, Leroith D, Brodt P.
    Cytokine Growth Factor Rev; 2005 Nov 01; 16(4-5):407-20. PubMed ID: 15886048
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J, Goldberg R, Maor G.
    Kidney Int; 2003 Feb 01; 63(2):487-500. PubMed ID: 12631114
    [Abstract] [Full Text] [Related]

  • 17. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
    Yi Y, Zeng S, Wang Z, Wu M, Ma Y, Ye X, Zhang B, Liu H.
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar 01; 1864(3):793-803. PubMed ID: 29253515
    [Abstract] [Full Text] [Related]

  • 18. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits.
    Savino W, de Mello-Coelho V, Dardenne M.
    Neuroimmunomodulation; 1995 Mar 01; 2(6):313-8. PubMed ID: 8840333
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.
    Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM.
    Cancer Res; 2004 Sep 15; 64(18):6549-55. PubMed ID: 15374967
    [Abstract] [Full Text] [Related]

  • 20. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005 Sep 15; 6(2):120-7. PubMed ID: 15777106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.